Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2022-08-16 Major Shareholding Noti…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Disclosure of Dealings under Rule 22 of the Takeovers Code
Major Shareholding Notification Classification · 95% confidence The document is a Public Disclosure Form dated 16 August 2022, detailing securities dealings related to a possible offer. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers and discloses derivative transactions by a financial trading entity connected with the offeror. The content focuses on share dealings and disclosures related to a takeover context, not a full report or financial statement. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related disclosures in the context of takeovers.
2022-08-16 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 95% confidence The document is titled 'Public Disclosure Form' and details securities dealings by CICC Financial Trading Limited, including dates, types of securities, nature of dealings, purchase/sale information, and amounts involved. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is a disclosure related to share transactions by a party connected to a possible offer. The content is focused on insider or related party share transactions rather than financial results, management changes, or regulatory announcements. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives or related parties. The document length is short and specific to share dealings, not a broader report or announcement. Therefore, the appropriate classification is DIRS (Director's Dealing).
2022-08-16 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from CStone Pharmaceuticals regarding the date of a board meeting to consider and approve the interim results for the six months ended June 30, 2022, and the potential payment of an interim dividend. It does not contain the actual interim financial results or detailed financial data, but rather informs about the upcoming board meeting where such results will be reviewed and published. The document length is only 1587 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement about the timing of a report (interim results) rather than the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-08-15 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Major Shareholding Notification Classification · 95% confidence The document is a Public Disclosure Form dated 15 August 2022, reporting dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to disclosure of securities dealings by an exempt principal trader connected with an offeror. The content is focused on share transactions and derivative dealings, not on financial results, management changes, or regulatory filings unrelated to share dealings. This fits the definition of a Major Shareholding Notification, which covers notifications of changes in significant share ownership levels or related securities dealings.
2022-08-15 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 95% confidence The document is a Public Disclosure Form reporting dealings in shares of Yankuang Energy Group Company Limited. It details specific transactions of shares by CICC Financial Trading Limited, including dates, nature of dealings, and prices paid. The content focuses on insider or related party share transactions rather than financial results, management changes, or regulatory announcements. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives or related parties. The document length is short and specific to share dealings, confirming it is not a full financial report or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-08-15 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 95% confidence The document is a Public Disclosure Form reporting dealings in shares of Yankuang Energy Group Company Limited. It references securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to share transactions by a party connected with an offeror. The content focuses on disclosure of share dealings, not on financial results, management changes, or other report types. The document length is short (1574 characters) and it is a formal notification of share transactions by a connected party. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives or connected parties. Therefore, the correct classification is DIRS with high confidence.
2022-08-12 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.